Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
Condition(s):Ventricular Premature Complexes; Myocardial IschemiaLast Updated:January 29, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Ventricular Premature Complexes; Myocardial IschemiaLast Updated:January 29, 2020Completed
Condition(s):Stable Angina; Metabolic SyndromeLast Updated:April 10, 2020Completed
Condition(s):Pulmonary Hypertension; Diastolic Left Ventricular DysfunctionLast Updated:May 17, 2017Completed
Condition(s):Chronic Stable AnginaLast Updated:April 3, 2018Unknown status
Condition(s):Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1Last Updated:March 5, 2019Completed
Condition(s):CardiomyopathyLast Updated:February 18, 2020Terminated
Condition(s):Diarrhea Predominant Irritable Bowel SyndromeLast Updated:March 15, 2016Terminated
Condition(s):Premature Ventricular BeatsLast Updated:May 1, 2015Unknown status
Condition(s):Microvascular AnginaLast Updated:May 21, 2019Completed
Condition(s):End-stage Renal Disease; Cardiovascular DiseaseLast Updated:October 16, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.